Although increases in FGF23 help to maintain normophosphatemia until late in the course of CKD [2, 5], FGF23-induced suppression of 1,25-dihydroxyvitamin D contributes to secondary hyperparathyroidism. The gene discussed is FGF23; the disease is chronic kidney disease.